Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Prakash Paudyal
    Department of Pharmacology
    The University of Lowa
    USA
    ppaudyal2003@yahoo.com
    GJCT

    Research Interest: Role of GPCR signaling in cancer progression and metastasis.


    More Info.
    Wei Du
    Hematology and Cancer Biology
    Cincinnati Childrens Hospital Medical Center
    USA
    Wei.Du@cchmc.org
    GJCT

    Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


    More Info.
    Ryou-U Takahashi
    Division of Molecular and Cellular Medicine
    National Cancer Center Research Institute
    Japan
    rytakaha@ncc.go.jp
    GJCT

    Research Interest: Molecular And Cell Biology, Microrna, Breast Cancer, Cancer Stem Cells


    More Info.
    Edgar Selzer
    Professor
    Landesklinikum Wiener Neustadt
    Medical University Vienna
    Austria
    eselze82@gmail.com
    GJCT

    Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research


    More Info.
    Hidenari Nagai
    Department of Internal Medicine
    Toho University
    Japan
    hidenari@aol.com
    GJCT

    Research Interest:  I Am Interested In Strategy Of Hepatocellular Carcinoma And Especially I Am Interested In Host Immunity In Patients With Liver Cirrhosis And Hepatocellular Carcinoma.


    More Info.
    Rui-An Wang
    Professor
    Department of Pathology and Pathobiology
    The Fourth Military Medical University
    China
    wangra@fmmu.edu.cn
    GJCT

    Research Interest: Theory and Mechanisms of Carcinogenesis and Metastasis; Breast Cancer; Endocrinology


    More Info.
    Zhu Shu
    Yale University
    USA
    shu.zhu@yale.edu
    GJCT

    Research Interest: To Study How Our Immune Systems Recognize “Self” (The Host) Or “Non-¬‐Self” (Foreign Material) Antigens, And How The Break Of These Processes Leads To The Consequent Disease Pathology, Including Infectious Diseases And Autoimmune Diseases.


    More Info.
    Andrey Akopov
    Professor
    Pavlov First State Medical University
    Russia
    akopovand@mail.ru
    GJCT

    Research Interest: Lung Cancer, Surgery, Neoadjuvant Therapy, Photodynamic Therapy, Targeted Therapy, Malignant Pleural Effusion, Endobronchial Therapy.


    More Info.
    Maria Saridi
    Director Nursing
    University of Peloponnese
    Greece
    sarmar32@windowslive.com
    GJCT
    Research Interest: Nursing Care Delivery Systems, Community Nursing, Hospital Information Systems, Surgical Nursing, Health Education, Prevention, Nosocomial Infections, Occupational Health, Community Healthcare
    More Info.
    Haruo Sugiyama
    Professor
    Department of Functional Diagnostic Science
    Osaka University
    Japan
    sugiyama@sahs.med.osaka-u.ac.jp
    GJCT

    Research Interest: WT1-Specific Cytotoxic T-Lymphocytes That Have The Potential To Attack Tumor Cells


    More Info.
    Gang Zhao
    Professor
    Department of Pancreatic Surgery
    Huazhong University of Science and Technology
    China
    gangzhao@aliyun.com
    GJCT
    More Info.
    Tomasz Skora
    Gastrointestinal and Genitourinary Cancer
    Maria Sklodowska-Curie Memorial Institute
    Poland
    tbskora@gmail.com
    GJCT

    Research Interest: Radiotherapy, Proton Therapy, Particle Therapy, Gastrointestinal Cancers, Genitourinary Cancers, Anal Canal Cancer, Rectal Cancer, Gastric Cancer, Seminoma, Bladder Cancer, Prostate Cancer


    More Info.
    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan
    Jordan
    habdelrazeq@KHCC.JO
    GJCT

    Research Interest: Clinical Oncology

    More Info.
    Mirela Sedic
    Assistant Professor
    Department of Biotechnology
    University of Rijeka
    Croatia
    msedic@biotech.uniri.hr
    GJCT

    Research Interest: Her Major Scientific Interests Include Cancer Biology And Treatment, With Particular Emphasis On Sphingolipid Signalling In Cancer.


    More Info.
    Julius Strauss
    Associate Investigator
    National Cancer Institute
    Thomas Aquinas College
    USA
    julius.strauss@nih.gov
    GJCT

    Research Interest: Cancer Immunotherapies  Therapeutic Cancer Vaccines, Genitourinary Malignancies

    More Info.
    View more
    mendeley

    Experiences of women receiving high dose rate brachytherapy for cervical cancer at ocean road cancer institute Dar-es-salaam Tanzania

    DOI Logo 10.17352/2581-5407.000031

    Published On: August 18, 2020 | Pages: 023 - 027

    Author(s): Francis Kazoba* and Nazima Dharsee
    Abstract View Full Article View
    mendeley

    Efficacy of Neutron Radiotherapy for Primary Tracheal Adenoid Cystic Carcinoma: A Single Institution Retrospective Analysis

    DOI Logo 10.17352/2581-5407.000030

    Published On: May 22, 2020 | Pages: 015 - 022

    Author(s): Shilpen Patel*, Christine Y Chon, Laura Tedrick, Joshua K Calvert, Dean Lorimer, Justin R Shinn, Jing Zeng and George E Laramore
    Abstract View Full Article View
    mendeley

    Modern applications of cryosurgery in oncology

    DOI Logo 10.17352/2581-5407.000029

    Published On: May 19, 2020 | Pages: 010 - 014

    Author(s): Karthikeyan M*, Deepa MK*, Balasubramanian T, Monika Reji, Satish RC, Abhay AD, Shruti PC and Omkar SD
    Abstract View Full Article View
    mendeley

    Rare Case Botryoid Rhabdomyosarcomas of the Genital Tract. About a case in a 30-month-old child

    DOI Logo 10.17352/2581-5407.000028

    Published On: April 30, 2020 | Pages: 007 - 009

    Author(s): M Lahfaoui* and H Benhaddou
    Abstract View Full Article View
    mendeley

    FMTVDM-Breast Cancers Diagnostic Doorway from Qualitative to Quantitative Measurement, Care and Treatment

    DOI Logo 10.17352/2581-5407.000027

    Published On: April 13, 2020 | Pages: 004 - 006

    Author(s): Richard M Fleming*, Matthew R Fleming, William C Dooley
    Abstract View Full Article View
    mendeley

    A prospective for the role of two-pore channels in breast cancer cells

    DOI Logo 10.17352/2581-5407.000026

    Published On: March 30, 2020 | Pages: 001 - 003

    Author(s): Hengrui Liu*
    Abstract View Full Article View
    mendeley

    Contribution of viruses to cancer and its global burden

    DOI Logo 10.17352/2581-5407.000025

    Published On: August 20, 2019 | Pages: 012 - 015

    Author(s): Shahzeb Khan Shaz*
    Abstract View Full Article View
    mendeley

    A Novel Nutrient Mixture Induces Apoptosis in Human Mesothelioma Cells (MSTO-211H) via Activation of Caspases

    DOI Logo 10.17352/2581-5407.000024

    Published On: April 09, 2019 | Pages: 007 - 011

    Author(s): M Waheed Roomi, Bilwa Bhanap, Aleksandra Niedzwiecki* and Matthias Rath
    Abstract View Full Article View
    mendeley

    Synthesis of Some Aryl Ketoxime Derivatives with their in vitro Anti-microbial and Cytotoxic Activity

    DOI Logo 10.17352/gjct.000023

    Published On: March 08, 2019 | Pages: 001 - 006

    Author(s): Oguzhan Karaosmanoglu, Burcu Butun*, Hakan Dal, Hulya Sivas and Kadriye Benkli
    Abstract View Full Article View
    mendeley

    Total Oncology is necessary for Japanese new era

    DOI Logo 10.17352/2581-5407.000022

    Published On: October 13, 2018 | Pages: 001 - 003

    Author(s): Tsuyoshi Shirakawa*
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT